Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
HUMANOID
Show more
Scientific research and development related to a line of cells for building and validating pre-clinical healthy and disease models as platforms for research and drug development
Class 42 – Technology & SaaS
Status timeline
- 8 May 2020Application filedNew Application Entered
- 28 Jun 2020Assigned to an examining attorneyAssigned To Examiner
- 29 Jun 2020Office action issuedNon-Final Action Written
- 29 Dec 2020Response to office action filedTeas Response To Office Action Received
- 26 Jan 2021Final refusal issuedFinal Refusal Mailed
- 20 Nov 2021Approved for publicationApproved For Pub - Principal Register
- 28 Dec 2021Published for oppositionPublished For Opposition
- 22 Feb 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 12 Aug 2022Statement of use filedTeas Statement Of Use Received
- 20 Sep 2022Statement of use acceptedAllowed Principal Register - Sou Accepted
- 21 Sep 2022Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 25 Oct 2022Registered on the Principal RegisterRegistered-Principal Register
All 29 events
| 2022-10-25 | Registered-Principal Register |
| 2022-10-25 | Notice Of Registration Confirmation Emailed |
| 2022-09-21 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2022-09-20 | Allowed Principal Register - Sou Accepted |
| 2022-08-26 | Case Assigned To Intent To Use Paralegal |
| 2022-08-26 | Statement Of Use Processing Complete |
| 2022-08-12 | Teas Statement Of Use Received |
| 2022-08-12 | Use Amendment Filed |
| 2022-02-22 | Noa Mailed - Sou Required From Applicant |
| 2021-12-28 | Published For Opposition |
| 2021-12-28 | Official Gazette Publication Confirmation E-Mailed |
| 2021-12-08 | Notification Of Notice Of Publication E-Mailed |
| 2021-11-21 | Exparte Appeal Terminated |
| 2021-11-20 | Approved For Pub - Principal Register |
| 2021-09-28 | Jurisdiction Restored To Examining Attorney |
| 2021-07-26 | Exparte Appeal Received At Ttab |
| 2021-07-26 | Ex Parte Appeal-Instituted |
| 2021-01-26 | Final Refusal Mailed |
| 2021-01-26 | Final Refusal E-Mailed |
| 2021-01-26 | Notification Of Final Refusal Emailed |
| 2020-12-30 | Teas/Email Correspondence Entered |
| 2020-12-29 | Teas Response To Office Action Received |
| 2020-12-29 | Correspondence Received In Law Office |
| 2020-06-29 | Non-Final Action Written |
| 2020-06-29 | Non-Final Action E-Mailed |
| 2020-06-29 | Notification Of Non-Final Action E-Mailed |
| 2020-06-28 | Assigned To Examiner |
| 2020-05-17 | New Application Office Supplied Data Entered |
| 2020-05-08 | New Application Entered |
Goods & services by class
Class 42 Technology & SaaS
Scientific research and development related to a line of cells for building and validating pre-clinical healthy and disease models as platforms for research and drug development
First use anywhere 1 Apr 2019 · First use in commerce 1 Apr 2019
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 25 Oct 2022; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.